Treatment of BDNF-related disorders using laquinimod

Details for Australian Patent Application No. 2010282948 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Hayardeny, Liat

Agent FB Rice

Pub. Number AU-A-2010282948

PCT Pub. Number WO2011/019375

Priority 61/273,920 10.08.09 US

Filing date 9 August 2010

Wipo publication date 17 February 2011

International Classifications

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/019375 Priority application(s): WO2011/019375

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282955-Orthodontic methods and devices

2010282936-Electrical storage device including oxide-ion battery cell bank and module configurations